Richard Warburg

Richard Warburg

Plus aucun poste en cours

Health Technology
Commercial Services
Consumer Services

Profil

Dr. Richard Warburg is a recognized authority on successful strategies for advancing pharmaceuticals and related matters, including working with companies such as ADC Therapeutics, Sugen, Plexxikon, and Afferant and being a key player in the DNA sequencing litigation over SEQUENASE DNA polymerase.
He has been involved in the successful advancement of many pharmaceuticals from preclinical to clinical and beyond.
He is a General Partner of Scientia Ventures since its inception.
Previously, he was the Managing Director, Intellectual Property and Licensing, for Auven Therapeutics Management LLLP.
Additionally, Dr. Warburg is the owner and founder of Godney Holdings, LLC, an IP consulting and management firm based out of St Thomas, US Virgin Islands.
Dr. Warburg was a partner at the law firms of Foley & Lardner LLP and Lyon & Lyon, and a law clerk with Fish & Richardson.
Dr. Warburg has over 30 years’ experience in intellectual property litigation, strategic counseling, licensing and patent prosecution.
Dr. Warburg has significant appellate, litigation, interference and worldwide prosecution and opposition experience in most technical areas including bio pharmacology, proteomics, antisense, and diagnostic devices.
Dr. Warburg is registered to practice before the U.S.
Patent and Trademark office.
He is admitted to practice in California and Massachusetts.
Dr. Warburg is a graduate of Birmingham University, England, where he received his Bachelor of Science degree in 1978 and his Ph.D.
in molecular biology in 1981.
After a post-doctoral fellowship at Brandeis University, acting as an adjunct professor at Wellesley College, and an instructor at University of Massachusetts, he attended Suffolk University law school and graduated valedictorian magna cum laude in 1990.
Dr. Warburg is the inventor on world-wide patents for a micro-centrifuge tube opening device, the inventor of the PATENTIAL board game concerning the biotech business model.

Postes actifs de Richard Warburg

SociétésPosteDébut
Directeur/Membre du Conseil 01/01/2018
Directeur/Membre du Conseil 01/08/2019
Directeur/Membre du Conseil 01/01/2018
Directeur/Membre du Conseil -
Private Equity Investor 01/01/2016
Directeur/Membre du Conseil 01/01/2019
Directeur/Membre du Conseil 01/01/2018
Tous les postes actifs de Richard Warburg

Anciens postes connus de Richard Warburg

SociétésPosteFin
Private Equity Investor 01/10/2019
Corporate Officer/Principal 01/01/2010
░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Richard Warburg

Formation de Richard Warburg

University of Birmingham Doctorate Degree
Suffolk University Law School Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Richard Warburg

Relations

100 +

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
ADC THERAPEUTICS SA

Health Technology

Entreprise privées12

Commercial Services

Commercial Services

Commercial Services

Health Technology

Technology Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Richard Warburg
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT